Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis

Journal of Internal Medicine

Volumn 281, Issue 6, 2017, Pages 611-619

  Muchtar, E ^a   Dean, D S ^a   Dispenzieri, A ^a   Dingli, D ^a   Buadi, F K ^a   Lacy, M Q ^a   Hayman, S R ^a   Kapoor, P ^a   Leung, N ^a   Russell, S ^a   Lust, J A ^a   Lin, Yi ^a   Warsame, R ^a   Gonsalves, W ^a   Kourelis, T V ^a   Go, R S ^a   Chakraborty, R ^a,b   Zeldenrust, S ^a   Kyle, R A ^a   Rajkumar, S Vincent ^a   Kumar, S K ^a   Gertz, M A ^a   more..

^a MAYO CLINIC   (United States)

^b Essentia Health St Joseph s Hospital   (United States)

Author keywords

amiodarone; amyloidosis; hypothyroidism; prognosis; proteinuria; thyroid

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; AMYLOID; LEVOTHYROXINE; LIOTRIX; SERUM ALBUMIN; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; TROPONIN T; ANTIBODY; IODIDE PEROXIDASE; THYROXINE;

ADULT; AGED; AL AMYLOIDOSIS; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; GLOMERULUS FILTRATION RATE; HORMONE SUBSTITUTION; HUMAN; LIGHT CHAIN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SUBCLINICAL HYPOTHYROIDISM; SURVIVAL RATE; THYROID FUNCTION; THYROID FUNCTION TEST; AMYLOIDOSIS; BLOOD; COMORBIDITY; HYPOTHYROIDISM; IMMUNOLOGY; KIDNEY DISEASES; LIVER DISEASES; MIDDLE AGED; MORTALITY; SURVIVAL ANALYSIS;

AGED; AMYLOIDOSIS; ANTIBODIES; COMORBIDITY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; KIDNEY DISEASES; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL ANALYSIS; THYROID HORMONES; THYROTROPIN; THYROXINE;

EID: 85018719945     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12617     Document Type: Article

References (21)

1. Dahlin DC. Primary amyloidosis, with report of six cases. Am J Pathol 1949; 25: 105–23.
2. Ozdemir BH, Uyar P, Ozdemir FN. Diagnosing amyloid goitre with thyroid aspiration biopsy. Cytopathology 2006; 17: 262–6.
3. Arean VM, Klein RE. Amyloid goiter. Review of the literature and report of a case. Am J Clin Pathol 1961; 36: 341–55.
4. Duhra P, Cassar J. Thyroid function tests in amyloid goitre. Postgrad Med J 1990; 66: 304–6.
5. El-Reshaid KA, Hakim AA, Hourani HA, Seshadri MS. Endocrine abnormalities in patients with amyloidosis. Ren Fail 1994; 16: 725–30.
6. Kanoh T, Shimada H, Uchino H, Matsumura K. Amyloid goiter with hypothyroidism. Arch Pathol Lab Med 1989; 113: 542–4.
7. Kimura H, Yamashita S, Ashizawa K, Yokoyama N, Nagataki S. Thyroid dysfunction in patients with amyloid goitre. Clin Endocrinol (Oxf) 1997; 46: 769–74.
8. Law JH, Dean DS, Scheithauer B, Earnest FT, Sebo TJ, Fatourechi V. Symptomatic amyloid goiters: report of five cases. Thyroid 2013; 23: 1490–5.
9. Rich MW. Hypothyroidism in association with systemic amyloidosis. Head Neck 1995; 17: 343–5.
10. Sachchithanantham S, Roussel M, Palladini G et al. European collaborative study defining clinical profile outcomes and novel prognostic criteria in monoclonal immunoglobulin M-related light chain amyloidosis. J Clin Oncol 2016; 34: 2037–45.
11. Gertz MA, Comenzo R, Falk RH et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005; 79: 319–28.
12. Dispenzieri A, Gertz MA, Kyle RA et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004; 104: 1881–7.
13. Kumar S, Dispenzieri A, Lacy MQ et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 2012; 30: 989–95.
14. Chandurkar V, Shik J, Randell E. Exacerbation of underlying hypothyroidism caused by proteinuria and induction of urinary thyroxine loss: case report and subsequent investigation. Endocr Pract 2008; 14: 97–103.
15. Feinstein EI, Kaptein EM, Nicoloff JT, Massry SG. Thyroid function in patients with nephrotic syndrome and normal renal function. Am J Nephrol 1982; 2: 70–6.
16. Iglesias P, Diez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol 2009; 160: 503–15.
17. Gilles R, den Heijer M, Ross AH, Sweep FC, Hermus AR, Wetzels JF. Thyroid function in patients with proteinuria. Neth J Med 2008; 66: 483–5.
18. Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 2012; 35: 340–8.
19. Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid 2001; 11: 493–500.
20. Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM 2002; 95: 559–69.
21. Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 1995; 10: 344–50.